Cynata Therapeutics : 17.01.25.Notice Under Section 708A

25 January 2017

Company Announcements Office Australian Securities Exchange 20 Bridge Street

SYDNEY NSW 2000

Dear Sir/Madam

NOTICE UNDER SECTION 708A OF THE CORPORATIONS ACT

This notice is given by Cynata Therapeutics Limited pursuant to section 708A(5)(e) of the Corporations Act (Act).

The Company has today issued 8,088,403 fully paid ordinary shares (Transaction Shares) at an issue price of $0.49113 per share pursuant to the transaction with FUJIFILM announced on 19 January 2017.

Pursuant to section 708A(5)(e) of the Act, the Company gives notice that:

1. the Company issued the Transaction Shares without disclosure to investors under part 6D.2 of the Act;

2. as at the date of this notice, the Company has complied with:

3. the provisions of Chapter 2M of the Act as they apply to the Company; and

4. section 674 of the Act; and

5. 3. as at the date of this notice, there is no information that is "excluded information" (as defined in section 708A(7) of the Act) which is required to be disclosed by the Company.

   Yours faithfully

   Peter Webse

   Company Secretary

   Cynata Therapeutics Limited

   Suite 1, 1233 High Street, Armadale, Victoria 3143, Australia PO Box 7165, Hawthorn North, Victoria 3122

   T: + 613 9824 5254 F: + 613 9822 7735 E: [e-mail] ABN - 98 104 037 372